Breast cancer risk reduction using effective clinical intervention is supported by extensive epidemiological and clinical trials evidence. A major burden of breast cancer can be relieved through the application of current knowledge to women who are at increased risk for developing the disease after menopause.
From the Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Received April 2, 2008; revised and accepted April 2, 2008.
Financial disclosure: Consultant, research support and speaker's bureau-AstraZeneca, Eli Lilly.
Address correspondence to: Victor G. Vogel, MD, MHS, University of Pittsburgh Cancer Institute, Magee-Womens Hospital, 300 Halket Street, Room 3524, Pittsburgh, PA 15213-3180. E-mail: email@example.com